Crohn's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Crohn's Disease, including details on symptoms, diagnosis, treatment, causes, medication.

Volume 2 (2005), Issue 5 (May)

1. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis.
   J Gastroenterol, 40(4): 409-13. [Abstract] [Full-text]
2. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery.
   Dis Colon Rectum, 48(3): 464-8. [Abstract] [Full-text]
3. Long-term indwelling seton for complex anal fistulas in Crohn's disease.
   Dis Colon Rectum, 48(3): 459-63. [Abstract] [Full-text]
4. Polypharmacy and Crohn's disease.
   Aliment Pharmacol Ther, 21(10): 1211-6. [Abstract] [Full-text]
5. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease.
   Gut, 54(6): 789-96. [Abstract] [Full-text]
6. The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease.
   Dig Liver Dis, 37(3): 159-61. [Abstract] [Full-text]
7. Immune activation and nutritional status in adult Crohn's disease patients.
   Dig Liver Dis, 37(6): 424-31. [Abstract] [Full-text]
8. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
   J Dermatolog Treat, 16(1): 58-61. [Abstract] [Full-text]
9. Faecal calprotectin in the assessment of Crohn's disease activity.
   QJM, 98(6): 435-41. [Abstract] [Full-text]
10. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
    Ann Rheum Dis, 64(6): 930-5. [Abstract] [Full-text]
11. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
    Clin Chem Lab Med, 43(4): 403-11. [Abstract] [Full-text]
12. Local injection of Infliximab for the treatment of perianal Crohn's disease.
    Dis Colon Rectum, 48(4): 768-74. [Abstract] [Full-text]
13. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    Dis Colon Rectum, 48(4): 758-67. [Abstract] [Full-text]
14. Postoperative change of mucosal inflammation at strictureplasty segment in Crohn's disease: cytokine production and endoscopic and histologic findings.
    Dis Colon Rectum, 48(4): 749-57. [Abstract] [Full-text]
15. Airway obstruction secondary to tracheobronchial involvement of asymptomatic undiagnosed Crohn's disease in a pediatric patient.
    Int J Pediatr Otorhinolaryngol, 69(7): 1003-5. [Abstract] [Full-text]
16. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    Lancet, 365(9473): 1794-6. [Abstract] [Full-text]
17. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
    J Clin Pathol, 58(6): 568-72. [Abstract] [Full-text]
18. Sargramostim for active Crohn's disease.
    N Engl J Med, 352(21): 2193-201. [Abstract] [Full-text]
19. Impact of infliximab on serum leptin levels in patients with Crohn's disease.
    J Clin Endocrinol Metab, 90(6): 3510-6. [Abstract] [Full-text]

© 2004-2008 Crohn's Disease Research Today. All Rights Reserved.